These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 29069583)
1. shRNA interference of NLRP3 inflammasome alleviate ischemia reperfusion-induced myocardial damage through autophagy activation. Meng Z; Song MY; Li CF; Zhao JQ Biochem Biophys Res Commun; 2017 Dec; 494(3-4):728-735. PubMed ID: 29069583 [TBL] [Abstract][Full Text] [Related]
2. Activation of autophagy inhibits nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation and attenuates myocardial ischemia-reperfusion injury in diabetic rats. Zhang D; He Y; Ye X; Cai Y; Xu J; Zhang L; Li M; Liu H; Wang S; Xia Z J Diabetes Investig; 2020 Sep; 11(5):1126-1136. PubMed ID: 32064785 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of GSK-3β alleviates cerebral ischemia/reperfusion injury in rats by suppressing NLRP3 inflammasome activation through autophagy. Wang Y; Meng C; Zhang J; Wu J; Zhao J Int Immunopharmacol; 2019 Mar; 68():234-241. PubMed ID: 30703695 [TBL] [Abstract][Full Text] [Related]
4. Artemisinin suppresses myocardial ischemia-reperfusion injury via NLRP3 inflammasome mechanism. Wang F; Gao Q; Yang J; Wang C; Cao J; Sun J; Fan Z; Fu L Mol Cell Biochem; 2020 Nov; 474(1-2):171-180. PubMed ID: 32729005 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway. Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354 [TBL] [Abstract][Full Text] [Related]
6. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway. Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945 [TBL] [Abstract][Full Text] [Related]
7. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606 [TBL] [Abstract][Full Text] [Related]
8. Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation. Xu LJ; Chen RC; Ma XY; Zhu Y; Sun GB; Sun XB Phytomedicine; 2020 Mar; 68():153169. PubMed ID: 31999976 [TBL] [Abstract][Full Text] [Related]
9. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction. He Q; Li Z; Wang Y; Hou Y; Li L; Zhao J Int Immunopharmacol; 2017 Sep; 50():208-215. PubMed ID: 28683365 [TBL] [Abstract][Full Text] [Related]
11. NLRP3 gene silencing ameliorates phosgene-induced acute lung injury in rats by inhibiting NLRP3 inflammasome and proinflammatory factors, but not anti-inflammatory factors. He DK; Xu N; Shao YR; Shen J J Toxicol Sci; 2020; 45(10):625-637. PubMed ID: 33012731 [TBL] [Abstract][Full Text] [Related]
12. 6-Gingerol protects against cerebral ischemia/reperfusion injury by inhibiting NLRP3 inflammasome and apoptosis via TRPV1 / FAF1 complex dissociation-mediated autophagy. Luo J; Chen J; Yang C; Tan J; Zhao J; Jiang N; Zhao Y Int Immunopharmacol; 2021 Nov; 100():108146. PubMed ID: 34537481 [TBL] [Abstract][Full Text] [Related]
13. [The Effect of Interference of Jia HL; Lu CQ; Wang J; Ren DD; Chen YQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):7-12. PubMed ID: 31037898 [TBL] [Abstract][Full Text] [Related]
14. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway. Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283 [TBL] [Abstract][Full Text] [Related]
15. NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats. Qiu Z; Lei S; Zhao B; Wu Y; Su W; Liu M; Meng Q; Zhou B; Leng Y; Xia ZY Oxid Med Cell Longev; 2017; 2017():9743280. PubMed ID: 29062465 [TBL] [Abstract][Full Text] [Related]
16. Geniposide inhibits NLRP3 inflammasome activation via autophagy in BV-2 microglial cells exposed to oxygen-glucose deprivation/reoxygenation. Fu C; Zhang X; Lu Y; Wang F; Xu Z; Liu S; Zheng H; Liu X Int Immunopharmacol; 2020 Jul; 84():106547. PubMed ID: 32361652 [TBL] [Abstract][Full Text] [Related]
17. Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway. Wang Q; Lin P; Li P; Feng L; Ren Q; Xie X; Xu J Life Sci; 2017 Oct; 186():50-58. PubMed ID: 28782532 [TBL] [Abstract][Full Text] [Related]
18. Protective Effect of Ethyl Pyruvate against Myocardial Ischemia Reperfusion Injury through Regulations of ROS-Related NLRP3 Inflammasome Activation. Jun JH; Shim JK; Oh JE; Shin EJ; Shin E; Kwak YL Oxid Med Cell Longev; 2019; 2019():4264580. PubMed ID: 30728885 [TBL] [Abstract][Full Text] [Related]
19. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429 [TBL] [Abstract][Full Text] [Related]
20. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation. Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]